(lp0
S'Enzon Pharmaceuticals Selling Well Below Likely Future Distributions Seeking Alpha - May 25, 2016 Enzon Pharmaceuticals , formerly a development-stage darling, is now a $17 million market cap cigar-butt, which receives royalties on several drugs.'
p1
aS'Enzon Pharmaceuticals: Remaining Royalties Priced In, But Door Still Open To ... Seeking Alpha - 13 hours ago Enzon Pharmaceuticals is winding down operations, distributing royalties on legacy products before its last patent expires in 2021.Analyst Advice And Earnings Insight: Planet Fitness, Inc. , Enzon ... - Post AnalystSell-side Analyst PT &amp; Stock Updates on Enzon Pharmaceuticals, Inc. (NASDAQ ... - Rives Journal'
p2
aS'0.25 MarketWatch - Nov 9, 2009 Enzon Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in the provision of licensing arrangements.'
p3
aS"Warning! Enzon Pharmaceuticals Is Definitely Going To $0 Seeking Alpha - Jan 14, 2014 Finance profile for the company! Right off the bat, that doesn't give us a lot of confidence, now does it? Enzon Pharmaceuticals  used to be a research stage biotech firm, focusing on a technology known as PEGylation. PEGylation was used ..."
p4
aS"Enzon Pharmaceuticals Inc : Icahn's Done His Sums Insider Financial - Dec 2, 2016 Enzon Pharmaceuticals Inc  is an interesting one. The company just gained close to 25% on a 13G filing that revealed Carl Icahn has a close to 15% holding, and has held a position since at least July last year."
p5
aS"Legendary Investor Icahn Still Slugging Away With Enzon Pharma Seeking Alpha - Jan 8, 2013 Carl C. Icahn has been the principal beneficial shareholder of Icahn Enterprises L.P.  and has served as Chairman of the board, a director, and an owner of the company's general partner since 1990. Mr. Icahn heads the investment management&nbsp;..."
p6
aS'Enzon Pharmaceuticals Inc  Hooks the Big Fish The Oracle Dispatch - Nov 30, 2016 Enzon Pharmaceuticals Inc  is a penny play that just did something rather confusing for many folks until you know one new fact.'
p7
aS'Enzon Pharmaceuticals, Inc.  Ex-Dividend Date Scheduled for January 08, 2015 Nasdaq - Jan 7, 2015 Enzon Pharmaceuticals, Inc.  will begin trading ex-dividend on January 08, 2015. A cash dividend payment of $0.1 per share is scheduled to be paid on January 28, 2015.'
p8
aS'Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals GuruFocus.com - Dec 2, 2016 Enzon was formerly a research stage biopharmaceutical company known for its Customized PEGylation Linker Technology.'
p9
aS"BRIEF-Enzon Pharmaceuticals enters into standstill agreement with Icahn and ... Reuters - Dec 8, 2016 SHANGHAI, April 8 In Beijing's latest push to attract foreign investment into the country's $9 trillion bond market, China's state-owned clearing house said on Saturday that it will work with Canada's TMX Group to expedite cross-border investments."
p10
a.